(Reuters) -Trump administration officials, including Health Secretary Robert F. Kennedy Jr. have discussed scaling back the role of Marty Makary, the Food and Drug Administration commissioner, The Wall Street Journal reported on Saturday, citing people familiar with the matter.
Reuters could not immediately verify the report.
(Reporting by Anusha Shah in Bengaluru, Editing by Louise Heavens)
0 Comments